/Lilly(Eli)%20%26%20Co%20logo%20on%20building-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading pharmaceutical company that sells Trulicity, Verzenio and Taltz drugs. The company discovers, develops, and markets human pharmaceuticals. With a market cap of $912.4 billion, LLY’s products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.
Companies worth $200 billion or more are generally described as “mega-cap stocks,” and LLY definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the general drug manufacturers industry. Eli Lilly's diversified product portfolio allows it to meet various medical needs and reduce reliance on any single product. Its robust financial performance reflects operational efficiency and effective strategies, providing the stability necessary for investments in research and development, acquisitions, and market expansion.
